文献速递角膜与眼表疾病

初次与二期Boston角膜假体1型植入的长期结局比较

Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation.
PubMed 文献 · Br J Ophthalmol · 2021-02-23

两组视力均改善,但初次组特发性玻璃体炎、脉络膜脱离、新发青光眼更多且假体保留率更低(70% vs 91%)。结论认为初次植入视力结局良好但并发症更多,对预计植片失败者仍为有利选择。

要点

  • 初次与二期KPro术后视力均改善,5年时平均BCVA相似。
  • 初次KPro的特发性玻璃体炎、脉络膜脱离和新发青光眼发生率显著更高。
  • 初次KPro假体保留率更低(70% vs 91%),无虹膜眼占移除的50%。

核心结论

  • 初次KPro长期视力结局良好,但并发症更多、保留率低于二期KPro,可能与术前指征有关。
  • 对预计植片失败的患者,初次植入KPro是 favorable 的选择。

研究设计与样本

  • 回顾性医学记录审查,纳入2008–2017年Montréal大学医院中心接受KPro植入、术前BCVA≤20/100且随访≥5年的患者。

主要发现

  • 两组BCVA各年较基线改善;初次组术后5年均显著,二期组前3年显著(p<0.05)。
  • 5年时平均BCVA相似:初次组logMAR 1.3±0.8,二期组1.5±0.8(p<0.05)。
  • 初次组特发性玻璃体炎(17.5% vs 2.4%)、脉络膜脱离(27.5% vs 7.14%)、新发青光眼(35% vs 14%)更多(p<0.05)。
  • 末次随访初次组保留率更低(70% vs 91%,p<0.05);初次组无虹膜更多(48% vs 14%,p<0.01)。
  • 每组内50%的移除发生在无虹膜眼。

临床怎么用

  • 对预计植片失败的患者,初次KPro植入可作为有利选择,但需告知并发症和保留率风险。
  • 术后应重点监测特发性玻璃体炎、脉络膜脱离和新发青光眼,尤其初次KPro和无虹膜眼。

局限性

  • 术前指征差异可能解释两组并发症和保留率的不同。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIMS: To compare long-term outcomes of primary versus secondary (postgraft failure) Boston keratoprosthesis type 1 (KPro) implantation. METHODS: Medical records of patients at the Centre hospitalier de l'Université de Montréal having undergone KPro implantation between 2008 and 2017 were reviewed and included if they had a preoperative Snellen best-corrected visual acuity (BCVA) of 20/100 or worse and a minimum of 5 years of follow-up. Eighty-two eyes were separated into two cohorts (40 primary, 42 secondary KPro) and BCVA, complications and device retention were evaluated between groups. RESULTS: BCVA improved from baseline in both groups at each year; this was significant at all five postoperative years in the primary group and the first 3 years in the secondary group (p<0.05). Mean BCVA was similar between groups at 5 years (logarithm of minimal angle resolution 1.3±0.8 in the primary group vs 1.5±0.8 p<0.05). Idiopathic vitritis, choroidal detachment and new glaucoma occurred more after primary KPro (n=7, 17.5% vs n=1, 2.4%; n=11, 27.5% vs n=3, 7.14% and n=14, 35% vs n=6, 14%, respectively; p<0.05). Primary KPro had lower retention (n=28, 70% vs n=38, 91%, p<0.05) at final follow-up. There was more aniridia in the primary group (n=19, 48% vs n=6, 14%, p<0.01). Within each group, 50% of removals occurred in aniridic eyes. CONCLUSION: Primary KPro yielded favourable long-term visual outcomes but had more complications and lower retention rates than secondary KPro, likely explained by preoperative indications. Primary device implantation represents a favourable option for patients for whom grafts are likely to fail.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Nayman T, Bostan C, Szigiato AA, et al. Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation. Br J Ophthalmol. 2021. PMID: 33622700. doi:10.1136/bjophthalmol-2020-317606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。